Beutel, Goodman & Co’s Abbott ABT Stock Holding History

Beutel, Goodman & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.52M	Sell	24,570 -1,530	-6%	-$173K	0.02%	92
2025 Q4	$3.27M	Sell	26,100 -1,300	-5%	-$166K	0.02%	81
2025 Q3	$3.67M	Sell	27,400 -200	-0.7%	-$26.3K	0.02%	80
2025 Q2	$3.75M	Sell	27,600 -7,198	-21%	-$949K	0.02%	80
2025 Q1	$4.62M	Buy	34,798 +33,298	+2,220%	+$4.24M	0.03%	80
2024 Q4	$169K	Hold	1,500	–	–	﹤0.01%	73
2024 Q3	$171K	Buy	+1,500	New	+$165K	﹤0.01%	72
2023 Q1	–	Sell	-200	Closed	-$21K	–	75
2022 Q4	$21K	Hold	200	–	–	﹤0.01%	75
2022 Q3	$19K	Buy	+200	New	+$21.3K	﹤0.01%	72

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Beutel, Goodman & Co's ABT Position: Q1 2026 in Review

Beutel, Goodman & Co reduced its Abbott (ABT) stake by 5.9% in Q1 2026, selling an estimated $173K and leaving 24,570 shares worth $2.52M. The position accounts for 0.02% of the portfolio, ranked #92.

Beutel, Goodman & Co first reported a position in ABT in Q3 2022 and has held it in 9 quarters since. The position peaked at $4.62M in Q1 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Beutel, Goodman & Co held 24,570 shares of Abbott worth $2.52M as of Q1 2026.
Beutel, Goodman & Co sold 1,530 Abbott shares in Q1 2026, an estimated $173K.
Abbott made up 0.02% of Beutel, Goodman & Co's portfolio in Q1 2026, its #92 holding.
Beutel, Goodman & Co first reported a position in Abbott in Q3 2022 and has held it in 9 quarters since.
Beutel, Goodman & Co's Abbott position peaked at $4.62M in Q1 2025.
3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.